Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study

BACKGROUND: Hydroxychloroquine has not been associated with improved survival among hospitalized COVID-19 patients in the majority of observational studies and similarly was not identified as an effective prophylaxis following exposure in a prospective randomized trial. We aimed to explore the role...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Infect Dis
Autori principali: Ip, Andrew, Ahn, Jaeil, Zhou, Yizhao, Goy, Andre H., Hansen, Eric, Pecora, Andrew L., Sinclaire, Brittany A., Bednarz, Urszula, Marafelias, Michael, Sawczuk, Ihor S., Underwood, Joseph P., Walker, David M., Prasad, Rajiv, Sweeney, Robert L., Ponce, Marie G., La Capra, Samuel, Cunningham, Frank J., Calise, Arthur G., Pulver, Bradley L., Ruocco, Dominic, Mojares, Greggory E., Eagan, Michael P., Ziontz, Kristy L., Mastrokyriakos, Paul, Goldberg, Stuart L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7807228/
https://ncbi.nlm.nih.gov/pubmed/33446136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-021-05773-w
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi